Stay updated on IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe website’s displayed revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA notice announces NIH website changes and explains that some NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.5%

- Check28 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2, reflecting an update to the ClinicalTrials.gov website.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedThe record history now shows a new revision entry for v3.7.0 and removes the previous v3.6.6 entry, updating the list of study record versions.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry (v3.6.6) was added to the study history, superseding v3.6.5. This update concerns the record's metadata rather than any substantive changes to the study content or results.SummaryDifference0.1%

Stay in the know with updates to IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMU-131 HER-Vaxx in HER2+ Gastric Cancer Clinical Trial page.